TECHFIELDS INC has a total of 18 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in Japan, Australia and Republic of Korea. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BELL IAN M, CARRUTHERS NICHOLAS I and CALIFORNIA CAPITAL EQUITY LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 5 | |
#2 | Australia | 4 | |
#3 | Republic of Korea | 4 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Mexico | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Xu Lina | 18 |
#2 | Yu Chongxi | 18 |
Publication | Filing date | Title |
---|---|---|
JP2020147604A | Nsaia prodrug having very fast skin- and film-infiltration rate, and new use thereof as medicine | |
JP2019011336A | Nsaia prodrugs with extremely fast skin and membrane penetration speed and use thereof for novel medicines | |
JP2017105853A | Nsaia prodrug having very fast skin- and film-infiltration rate, and new use thereof as medicine | |
JP2015120703A | Nsaia prodrug having very fast skin- and film-infiltration rate, and new use thereof as medicine | |
JP2013147515A | Nsaia prodrug having very fast skin- and film-infiltration rate, and new use thereof as medicine | |
WO2008149181A1 | Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |